232 related articles for article (PubMed ID: 10792459)
1. Increased rewarding properties of morphine in dopamine-transporter knockout mice.
Spielewoy C; Gonon F; Roubert C; Fauchey V; Jaber M; Caron MG; Roques BP; Hamon M; Betancur C; Maldonado R; Giros B
Eur J Neurosci; 2000 May; 12(5):1827-37. PubMed ID: 10792459
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
Morice E; Denis C; Giros B; Nosten-Bertrand M
Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
[TBL] [Abstract][Full Text] [Related]
3. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core.
Sellings LH; Clarke PB
J Neurosci; 2003 Jul; 23(15):6295-303. PubMed ID: 12867514
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
[TBL] [Abstract][Full Text] [Related]
5. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
Sora I; Wichems C; Takahashi N; Li XF; Zeng Z; Revay R; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7699-704. PubMed ID: 9636213
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine.
Budygin EA; Brodie MS; Sotnikova TD; Mateo Y; John CE; Cyr M; Gainetdinov RR; Jones SR
Proc Natl Acad Sci U S A; 2004 May; 101(20):7781-6. PubMed ID: 15136721
[TBL] [Abstract][Full Text] [Related]
7. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
Drouin C; Darracq L; Trovero F; Blanc G; Glowinski J; Cotecchia S; Tassin JP
J Neurosci; 2002 Apr; 22(7):2873-84. PubMed ID: 11923452
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Noda Y; Nabeshima T
Biol Psychiatry; 2007 Sep; 62(6):658-68. PubMed ID: 17217924
[TBL] [Abstract][Full Text] [Related]
9. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice.
Chefer VI; Kieffer BL; Shippenberg TS
Eur J Neurosci; 2003 Oct; 18(7):1915-22. PubMed ID: 14622224
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
[TBL] [Abstract][Full Text] [Related]
11. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.
Urs NM; Daigle TL; Caron MG
Neuropsychopharmacology; 2011 Feb; 36(3):551-8. PubMed ID: 20980993
[TBL] [Abstract][Full Text] [Related]
12. Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal.
García-Pérez D; Núñez C; Laorden ML; Milanés MV
Addict Biol; 2016 Mar; 21(2):374-86. PubMed ID: 25522207
[TBL] [Abstract][Full Text] [Related]
13. Long-term opiate effects on amphetamine-induced dopamine release in the nucleus accumbens core and conditioned place preference.
He S; Li N; Grasing K
Pharmacol Biochem Behav; 2004 Feb; 77(2):327-35. PubMed ID: 14751461
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
[TBL] [Abstract][Full Text] [Related]
15. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
16. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.
Chen R; Tilley MR; Wei H; Zhou F; Zhou FM; Ching S; Quan N; Stephens RL; Hill ER; Nottoli T; Han DD; Gu HH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9333-8. PubMed ID: 16754872
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model.
Wu Y; Na X; Zang Y; Cui Y; Xin W; Pang R; Zhou L; Wei X; Li Y; Liu X
Biochem Biophys Res Commun; 2014 Jul; 449(4):502-7. PubMed ID: 24845379
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
[TBL] [Abstract][Full Text] [Related]
20. Dopamine neuronal transport kinetics and effects of amphetamine.
Jones SR; Joseph JD; Barak LS; Caron MG; Wightman RM
J Neurochem; 1999 Dec; 73(6):2406-14. PubMed ID: 10582600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
